Journal of Ethnopharmacology and Toxicology | Volume 2 Issue 2 | Pages: 44-55 | Doi : 10.37446/jet/rsa/2.2.2024.44-55

Research Article

OPEN ACCESS | Published on : 31-Dec-2024

Computational screening of phytochemicals as DPP-4 inhibitors for treating type 2 diabetes

• Ananta Swargiary
• Pharmacology and Bioinformatics Laboratory, Department of Zoology, Bodoland University, Kokrajhar, 783370, India.

Arup Swargiary
• Pharmacology and Bioinformatics Laboratory, Department of Zoology, Bodoland University, Kokrajhar, 783370, India.

Beauty Narzary
• Pharmacology and Bioinformatics Laboratory, Department of Zoology, Bodoland University, Kokrajhar, 783370, India.

Kalyan Dey
• Department of Physics, Bodoland University, Kokrajhar, 783370, India.

Dulur Brahma
• Pharmacology and Bioinformatics Laboratory, Department of Zoology, Bodoland University, Kokrajhar, 783370, India

Abstract

Dipeptidyl peptidase-4 (DPP4) is an enzyme responsible for degrading incretin hormones, which are key regulators of insulin secretion and blood glucose levels. Inhibition of DPP4 prolongs incretin activity, thereby enhancing glycemic control and offering therapeutic benefits in the management of Type 2 diabetes mellitus (T2DM). Although synthetic DPP4 inhibitors are commonly used, plant-based compounds present a promising and potentially safer alternative. This study aimed to evaluate the DPP4 inhibitory potential of plant-derived compounds through in silico approaches, including molecular docking, molecular dynamics (MD) simulations, and ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis. Among the screened compounds, Apigenin 7-O-methylglucuronide, a bioactive molecule, exhibited a higher binding affinity to DPP4 (-9.1 kcal/mol) compared to sitagliptin (-8.43 kcal/mol), a standard DPP4 inhibitor. Furthermore, MD simulations over 100 ns demonstrated greater stability of the Apigenin 7-O-methylglucuronide–DPP4 complex relative to the sitagliptin–DPP4 complex. ADMET profiling revealed favorable pharmacokinetic properties, including high oral bioavailability and minimal inhibition of cytochrome P450 enzymes. These findings underscore the potential of Apigenin 7-O-methylglucuronide as a natural DPP4 inhibitor and support its further investigation as a candidate for alternative T2DM therapies.

Keywords

Dipeptidyl peptidase-4 inhibitor, apigenin 7-O-methylglucuronide, molecular docking, molecular dynamics simulation, type 2 diabetes

References

• Abou Baker, D. H. (2022). An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up-to-date knowledge. Toxicology reports, 9, 445-469.

  Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1, 19-25.

  Alam, U., Asghar, O., Azmi, S., & Malik, R. A. (2014). General aspects of diabetes mellitus. Handbook of clinical neurology, 126, 211-222.

  Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome- a new worldwide definition. The Lancet, 366(9491), 1059-1062.

  Al-Saleh, Y., Sabico, S., Al-Furqani, A., Jayyousi, A., Alromaihi, D., Ba-Essa, E., & Al-Daghri, N. M. (2021). Sulfonylureas in the current practice of type 2 diabetes management: are they all the same? Consensus from the Gulf Cooperation Council (GCC) countries advisory board on sulfonylureas. Diabetes Therapy, 12(8), 2115-2132.

  American Diabetes Association. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33(Supplement 1), S62–S69.

  Bitew, M., Desalegn, T., Demissie, T. B., Belayneh, A., Endale, M., & Eswaramoorthy, R. (2021). Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study. Plos one, 16(12), e0260853.

  Deacon, C. F. (2020). Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nature Reviews Endocrinology, 16(11), 642-653.

  Doupis, J., & Veves, A. (2008). DPP4 inhibitors: a new approach in diabetes treatment. Advances in therapy, 25(7), 627-643.

  Feng, Y., Jin, C., Lv, S., Zhang, H., Ren, F., & Wang, J. (2023). Molecular mechanisms and applications of polyphenol-protein complexes with antioxidant properties: A review. Antioxidants, 12(8), 1577.

  Hospital, A., Goñi, J. R., Orozco, M., & Gelpí, J. L. (2015). Molecular dynamics simulations: advances and applications. Advances and Applications in Bioinformatics and Chemistry, 37-47.

  Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New England journal of medicine, 345(11), 790-797.

  Hu, M. (2007). Commentary: bioavailability of flavonoids and polyphenols: call to arms. Molecular pharmaceutics, 4(6), 803-806.

  Jakubec, D., Skoda, P., Krivak, R., Novotny, M., & Hoksza, D. (2022). PrankWeb 3: accelerated ligand-binding site predictions for experimental and modelled protein structures. Nucleic Acids Research, 50(W1), W593-W597.

  Kahn, C. R. (1994). Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes, 43(8), 1066-1085.

  Kaur, J., Singla, R., & Jaitak, V. (2018). In silico study of flavonoids as DPP-4 and α-glucosidase inhibitors. Letters in Drug Design & Discovery, 15(6), 634-642.

  Kharroubi, A. T., & Darwish, H. M. (2015). Diabetes mellitus: The epidemic of the century. World journal of diabetes, 6(6), 850.

  Kim, B. R., Kim, H. Y., Choi, I., Kim, J. B., Jin, C. H., & Han, A. R. (2018). DPP-IV inhibitory potentials of flavonol glycosides isolated from the seeds of Lens culinaris: in vitro and molecular docking analyses. Molecules, 23(8), 1998.

  Kumari, R., Kumar, R., Open Source Drug Discovery Consortium, & Lynn, A. (2014). g_mmpbsa: A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962.

  Li, N., Wang, L. J., Jiang, B., Guo, S. J., Li, X. Q., Chen, X. C., & Shi, D. Y. (2018). Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors. Bioorganic & medicinal chemistry letters, 28(12), 2131-2135.

  Lipinski, C. A. (2004). Lead-and drug-like compounds: the rule-of-five revolution. Drug discovery today: Technologies, 1(4), 337-341.

  Macalalad, M. A. B., & Gonzales III, A. A. (2023). In silico screening and identification of antidiabetic inhibitors sourced from phytochemicals of Philippine plants against four protein targets of diabetes (PTP1B, DPP-4, SGLT-2, and FBPase). Molecules, 28(14), 5301.

  O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of cheminformatics, 3(1), 33.

  Pan, J., Zhang, Q., Zhang, C., Yang, W., Liu, H., Lv, Z., & Jiao, Z. (2022). Inhibition of dipeptidyl peptidase-4 by flavonoids: Structure–activity relationship, kinetics and interaction mechanism. Frontiers in nutrition, 9, 892426.

  Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera - a visualization system for exploratory research and analysis. Journal of computational chemistry, 25(13), 1605-1612.

  Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of medicinal chemistry, 58(9), 4066-4072.

  Powers, A. C., Niswender, K. D., & Evans-Molina, C. (2022). Diabetes mellitus: diagnosis, classification, and pathophysiology. Diabetes, 1000, 415.

  Proença, C., Freitas, M., Ribeiro, D., Tomé, S. M., Araújo, A. N., Silva, A. M., & Fernandes, E. (2019). The dipeptidyl peptidase-4 inhibitory effect of flavonoids is hindered in protein rich environments. Food & function, 10(9), 5718-5731.

  Robertson, R. P. (1995). Antagonist: diabetes and insulin resistance--philosophy, science, and the multiplier hypothesis. The Journal of laboratory and clinical medicine, 125(5), 560-565.

  Shaikh, S., Lee, E. J., Ahmad, K., Ahmad, S. S., Lim, J. H., & Choi, I. (2021). A comprehensive review and perspective on natural sources as dipeptidyl peptidase-4 inhibitors for management of diabetes. Pharmaceuticals, 14(6), 591.

  Singh, A. K., Yadav, D., Sharma, N., & Jin, J. O. (2021). Dipeptidyl peptidase (DPP)-IV inhibitors with antioxidant potential isolated from natural sources: A novel approach for the management of diabetes. Pharmaceuticals, 14(6), 586.

  Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., & Magliano, D. J. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes research and clinical practice, 183, 109119.

  Swinnen, S. G., Hoekstra, J. B., & DeVries, J. H. (2009). Insulin therapy for type 2 diabetes. Diabetes care, 32(Suppl 2), S253.

  Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry, 31(2), 455-461.

  Udrea, A. M., Gradisteanu Pircalabioru, G., Boboc, A. A., Mares, C., Dinache, A., Mernea, M., & Avram, S. (2021). Advanced bioinformatics tools in the pharmacokinetic profiles of natural and synthetic compounds with anti-diabetic activity. Biomolecules, 11(11), 1692.

  Valdés-Tresanco, M. S., Valdés-Tresanco, M. E., Valiente, P. A., & Moreno, E. (2021). gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. Journal of chemical theory and computation, 17(10), 6281-6291.

  Velan, A., & Hoda, M. (2021). In-silico comparison of inhibition of wild and drug-resistant Haemonchus contortus β-tubulin isotype-1 by glycyrrhetinic acid, thymol and albendazole interactions. Journal of Parasitic Diseases, 45(1), 24-34.

  Vistoli, G., Pedretti, A., & Testa, B. (2008). Assessing drug-likeness–what are we missing? Drug discovery today, 13(7-8), 285-294.

  Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., & Cao, D. (2021). ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic acids research, 49(W1), W5-W14.

  Yang, Y., Shi, C. Y., Xie, J., Dai, J. H., He, S. L., & Tian, Y. (2020). Identification of potential dipeptidyl peptidase (DPP)-IV inhibitors among Moringa oleifera phytochemicals by virtual screening, molecular docking analysis, ADME/T-based prediction, and in vitro analyses. Molecules, 25(1), 189.

  Zoete, V., Cuendet, M. A., Grosdidier, A., & Michielin, O. (2011). SwissParam: a fast force field generation tool for small organic molecules. Journal of computational chemistry, 32(11), 2359-2368.